REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
06/06/2026
Voltar para busca
Dado oficial do USPTO
ATGLISTATIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ATGLISTATIN
ST13
US500000079161218Classe
1, 5, 42, 44
Pedido
79161218
Registro
5215604
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
73
Atualização mais recente
07/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
12/11/2014
Data de registro
06/06/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/09/2024
Última transação
07/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Graz, AT
Examinador
HALMEN, KATHERINE E
Localização atual
Historical data usage
Titulares e representantes
Titulares
U. G. (pessoa física)
Representantes
Isabella Hoedl, Esq.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and/or science
Classe 5
Pharmaceutical preparations for the treatment of diabetesdyslipidemiacachexiadiabetes; veterinary preparations for micecatdogmonkeyswinecattlerat and hamster for treating diabetesdyslipidemia and cachexia; dietary supplements for humans and animals
Classe 42
Scientific and technological services and researchscientific researchscientific investigations for medical purposesconducting scientific feasibility studiesmedical and scientific research in the field of cancer treatment and diagnosismedical and scientific researchconducting clinical trials for others; industrial analysischemical analysis of compounds related to adipose triglyceride lipasechemical analysis of compounds related to dyslipidemiachemical analysis of compounds related to cachexia; industrial research in the field of dyslipidemiaindustrial research in the field of cachexiadevelopment and establishment of testing specifications and procedures for the pharmaceutical industry
Classe 44
Medical services; veterinary services
Publicações
Histórico de despachos e eventos da marca no USPTO.
73 publicações encontradas
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/10/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
27/09/2025
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
20/08/2025
INPC
INVALIDATION PROCESSED
20/08/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/05/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/01/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
20/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/12/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/09/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
22/11/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/10/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/06/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/10/2017
GPNX
NOTIFICATION PROCESSED BY IB
06/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/09/2017
FIMP
FINAL DISPOSITION PROCESSED
14/09/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/09/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/03/2017
PUBO
PUBLISHED FOR OPPOSITION
21/03/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
25/10/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/08/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/08/2016
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/08/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/04/2016
GNRT
NON-FINAL ACTION E-MAILED
19/04/2016
CNRT
NON-FINAL ACTION WRITTEN
19/04/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2016
RFNT
REFUSAL PROCESSED BY IB
17/10/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2015
GNRT
NON-FINAL ACTION E-MAILED
08/09/2015
CNRT
NON-FINAL ACTION WRITTEN
08/09/2015
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
21/08/2015
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/08/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/07/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/07/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
16/07/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/07/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
16/07/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2015
ALIE
ASSIGNED TO LIE
24/06/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/06/2015
RFNT
REFUSAL PROCESSED BY IB
04/04/2015
MAFR
APPLICATION FILING RECEIPT MAILED
14/03/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/03/2015
RFRR
REFUSAL PROCESSED BY MPU
11/03/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/03/2015
CNRT
NON-FINAL ACTION WRITTEN
10/03/2015
DOCK
ASSIGNED TO EXAMINER
10/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/03/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATGLISTATIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.